Ion Beam Applications SA Overview
Pro stress-test →IBA is the world leader in particle accelerator technology and the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. The company develops solutions for the diagnosis and treatment of cancer and other serious illnesses.
Strategic Profile
Pro stress-test →IBA operates through two segments: Proton Therapy and Other Accelerators; and Dosimetry, where it provides solutions and services that enhance efficiency and minimize errors in radiation therapy and medical imaging quality assurance. The company is also a leading player in industrial sterilization, radiopharmaceuticals and dosimetry.
Competitive Landscape
Pro stress-test →IBA holds the #1 market position worldwide in both proton therapy equipment (55.5% of net sales) and dosimetry solutions (13.1% of net sales). The medical device market includes competitors such as Philips in diagnostic imaging and other accelerator manufacturers, but IBA maintains a specialized focus on precision oncology and particle acceleration technology.
Industry Context
Ion Beam Applications SA operates in Medical Devices & Equipment - Oncology & Radiation Therapy.
Key facts
Founded: 1986 · Headquarters: Louvain-la-Neuve, Belgium · Employees: 2,095 · Revenue: $539M · Market cap: $558.8M